Segments and Disaggregated Revenue (Tables)

6 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Schedule of Segments and Disaggregated Revenue

	Construction			Medical		Development			Corporate and support			Consolidated
Six Months Ended June 30, 2022
Revenue	$	5,956,354		$	10,203,215	$	—		$	—		$	16,159,569
Cost of revenue		5,996,473			6,904,701		—			—			12,901,174
Operating expenses		207,646			27,065		597,856			3,334,792			4,167,359
Operating income (loss)		(247,765	)		3,271,449		(597,856	)		(3,334,792	)		(908,964	)
Other income (expense)		490,903			—		(121,569	)		23,762			393,096
Income (loss) before income taxes		243,138			3,271,449		(719,425	)		(3,311,030	)		(515,868	)
Net income attributable to non-controlling interest		—			1,616,669		—			—			1,616,669
Net income (loss) attributable to common stockholders of SG Blocks, Inc.	$	243,138		$	1,654,780	$	(719,425	)	$	(3,311,030	)	$	(2,132,537	)
Total assets	$	10,907,679		$	2,322,505	$	8,902,271		$	10,007,048		$	32,139,503
Depreciation and amortization	$	286,755		$	26,820	$	21,569		$	—		$	335,144
Capital expenditures	$	821,400		$	28,621	$	893,785		$	8,193		$	1,751,999
Inter-segment revenue elimination	$	—		$	—	$	—		$	—		$	—
		Construction			Medical		Development			Corporate and support			Consolidated
Six Months Ended June 30, 2021
Revenue	$	5,300,161		$	15,741,453	$	—		$	—		$	21,041,614
Cost of revenue		7,300,202			11,323,405		—			—			18,623,607
Operating expenses		214,135			370,067		53,902			2,865,427			3,503,531
Operating income (loss)		(2,214,176	)		4,047,981		(53,902	)		(2,865,427	)		(1,085,524	)
Other income (expense)		332			13		—			91,254			91,599
Income (loss) before income taxes		(2,213,844	)		4,047,994		(53,902	)		(2,774,173	)		(993,925	)
Net income attributable to non-controlling interest		—			2,581,211		—			—			2,581,211
Net income (loss) attributable to common stockholders of SG Blocks, Inc.	$	(2,213,844	)	$	1,466,782	$	(53,902	)	$	(2,774,173	)	$	(3,575,136	)
Total assets	$	8,147,331		$	4,415,643	$	6,988,424		$	5,906,434		$	25,457,832
Depreciation and amortization	$	274,415		$	26,605	$	—		$	—		$	301,020
Capital expenditures	$	1,052,637		$	46,224	$	3,576,130		$	18,018		$	4,693,009

	Construction			Medical		Development			Corporate and support			Consolidated
Three Month Ended June 30, 2022
Revenue	$	4,237,585		$	3,317,386	$	—		$	—		$	7,554,971
Cost of revenue		4,275,759			2,507,252		—			—			6,783,011
Operating expenses		99,672			8,093		315,868			1,676,183			2,099,816
Operating income (loss)		(137,846	)		802,041		(315,868	)		(1,676,183	)		(1,327,856	)
Other income (expense)		372,223			—		(72,942	)		10,979			310,260
Income (loss) before income taxes		234,377			802,041		(388,810	)		(1,665,204	)		(1,017,596	)
Net income attributable to non-controlling interest		—			397,764		—			—			397,764
Net income (loss) attributable to common stockholders of SG Blocks, Inc.	$	234,377		$	404,277	$	(388,810	)	$	(1,665,204	)	$	(1,415,360	)
Depreciation and amortization	$	143,320		$	13,410	$	12,941		$	—		$	169,671
Capital expenditures	$	797,300		$	28,621	$	—		$	3,213		$	829,134
Inter-segment revenue elimination	$	—		$	—	$	—		$	—		$	—
		Construction			Medical		Development			Corporate and support			Consolidated
Three Months Ended June 30, 2021
Revenue	$	2,068,498		$	9,785,490	$	—		$	—		$	11,853,988
Cost of revenue		3,196,892			6,645,714		—			—			9,842,606
Operating expenses		207,986			210,813		53,902			1,462,748			1,935,448
Operating income (loss)		(1,336,380	)		2,928,963		(53,902	)		(1,462,748	)		75,933
Other income (expense)		695			13		—			73,784			74,492
Income (loss) before income taxes		(1,335,685	)		2,928,976		(53,902	)		(1,388,964	)		150,425
Net income attributable to non-controlling interest		—			1,691,684		—			—			1,691,684
Net income (loss) attributable to common stockholders of SG Blocks, Inc.	$	(1,335,685	)	$	1,237,292	$	(53,902	)	$	(1,388,964	)	$	(1,541,259	)
Depreciation and amortization	$	145,703		$	13,524	$	—		$	—		$	159,227
Capital expenditures	$	227,437		$	9,334	$	3,576,130		$	18,018		$	3,830,919